Determining Whether Multiple Anesthesia Exposures Affect Cognitive Function for Retinoblastoma Patients
Incidence of Neurocognitive Deficits in Patients After Treatment for Retinoblastoma With Multiple Anesthesia Exposures
Memorial Sloan Kettering Cancer Center
75 participants
May 7, 2018
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to see if there is a difference between the development of the brain (neurodevelopment) in children who have been treated for retinoblastoma with multiple anesthetic exposures, compared with brain development in children who have never had anesthesia.
Eligibility
Inclusion Criteria1
- Age ≥ 6 and < 17 years old
Exclusion Criteria9
- Diagnosis of any secondary disease associated with developmental delay
- History of second cancer diagnosis
- Legal Blindness
- Past surgery of any type, with the exception of enucleation for retinoblastoma
- Past exposure to anesthesia for surgical intervention
- More than one anesthesia encounter for surgical intervention before diagnosis at MSK
- Past External Beam Radiation for treatment of retinoblastoma
- Past systemic chemotherapy
- Non-native speaker of English; however, children whose parents speak only Spanish will be included, because the tests for parents are available in Spanish
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
the WISC-V assessment produces a Full Scale IQ (FSIQ) used for primary power consideration in this study. The FSIQ is the most comprehensive global ability score on the WISC-V, and it has been conventionally reported and interpreted as an estimation of overall intellectual ability
Used to assess verbal learning and memory in children and adolescents
Helps assess visual-motor skills in children and adults.
Measures dexterity
The Behavior Assessment System for Children/Parent Report is a questionnaire that assesses the social-emotional and behavioral functioning (e.g., anxiety, depression, attention, hyperactivity, adaptability, leadership, social skills, etc.) in children between the ages of 2 and 22 years, and is available in English and Spanish.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03546387